Molecular Detection of Circulating Prostate Cells in
Cancer II: Comparison of Prostate Epithelial Cells Isolation Procedures, Pierre Berteau, 1 Frédéric Dumas, 1 JeanLuc Gala, 2 Pascal Eschwège, 3 Bernard Lacour, 1 Marianne Philippe, 2 The sensitive and specific detection of circulating tumor cells holds great promise for more accurate staging of cancer patients. Several reverse transcription-PCR (RT-PCR) procedures based on tissue-specific mRNA expression are now able to detect one cell derived from a given tissue among Ͼ10 6 peripheral nucleated blood cells [PNBCs; for a review, see (1) ]. However, even for a single marker, highly discrepant results have been observed among the available clinical studies; e.g., the frequencies of positive prostate-specific antigen (PSA) RT-PCR results range from 25% (2) to 80% (3) in patients with metastatic prostate cancer (CaP), blurring the clinical relevance of these assays. Standardization and quality control in molecular diagnosis are crucial to the solution of this issue. We have previously studied factors potentially affecting RT-PCR results (4), and this current work focuses on the approaches for harvesting prostate cells among nucleated blood cells.
Since the first 1992 clinical report describing the RT-PCR detection of circulating prostatic cells in CaP, the majority of reported assays have used gradient separations to recover nucleated cells from the peripheral blood (1). We (5) and others (6) rather choose overnight hypoosmotic red blood cell lysis as an easier and more costeffective protocol. Because the approach used to harvest PNBCs may account for discrepancies in clinical results, we have compared a panel of nucleated blood cell separation methods.
Fresh blood from four healthy blood donors (total volume, 400 mL) was sampled in 40 ϫ 10-mL EDTAtreated tubes (Becton-Dickinson). The LNCaP cell line, derived from a metastatic prostate carcinoma, was cultured as described (7) . After trypsinization (2.5 mL/L trypsin), 10 5 confluent LNCaP cells were added into each of the 40 tubes, which were gently mixed. Six tubes were processed immediately by overnight hypoosmotic red blood cell lysis, as described (5, 6) : Two volumes of ammonium chloride (9 g/L) were mixed with 10 mL of blood in the first three tubes (5), whereas 1.5 volumes of diethylpyrocarbonate (DEPC)-treated water was added for 5 min in the other three tubes (6) . After centrifugation and removal of the supernatant, 1 mL of guanidinium thiocyanate was added to each tube, and RNA was extracted as described (8) . In method c, immuno-cytochemical analysis, immunostaining of serial layers was performed with a specific monoclonal anti-PSA antibody (IgG 1 M750 clone ER-PR8, Dako) at the final antibody concentration of 20 mg/L. Cells were fixed for 2 h in 40 g/L p-formaldehyde in phosphate-buffered saline (pH 7.4) at room temperature; cell smears were also labeled with a specific monoclonal anti-PSA antibody. Positive prostate cells were visualized by the alkaline phosphatase anti-alkaline phosphatase staining procedure, following manufacturer's recommendations (Dako APAAP kit).
In method d, PSA and prostate-specific membrane antigen (PSMA) RT-PCR assays were performed as already described (5) after normalization of the cDNAs by ␤-globin RT-PCR (9) . Briefly, 1 g of total RNA was used for cDNA first strand synthesis together with SuperScript II reverse transcriptase and 100 ng of oligo(dT) l2-18 as a template (Life Technologies). The ␤-globin, PSA, and PSMA genes were amplified as follows: 94°C for 1 min (2 min for the first cycle); 58°C, 60°C, and 62°C, respectively, for 1 min; and 72°C for 1 min (10 min for the last cycle) for 25 cycles. When RT-PCRs were negative, 3 L of PCR amplimers were amplified by 25 cycles of PSA or PSMA nested-PCR in the same upper conditions (9) . PCR products (15 L) were run on ethidium bromide-stained agarose gels (20 g/L) and visualized after transillumination. Fluorescence was captured with a digital camera and integrated by using NIH Image 1.7 software. Statistical analysis was performed on the results of three independent duplicate experiments, using GraphPad Prism/ Stat TM software. The results of these studies were grouped according to the four methods used.
In method a, banding density generated by prostate epithelial cells varied from one gradient to another (Fig.  1a) . The best separation was obtained with NycoPrep (d ϭ 1.068 kg/L) gradient, with cells collected at the interface between platelet-enriched plasma fraction and the gradient, suggesting a close correspondence of this value with the density of the main part of the LNCaP cells. Whereas prostate cancer cells have been reported to be isolated in a single band (d ϭ 1.056 kg/L) (10) when a mix of two different density layer gradients was used, the Percoll dilution of equivalent density (d ϭ 1.050 kg/L) gave a more spread population. Our findings confirm the results of Griwatz et al. (11) , who developed a new enrichment method for circulating epithelial cells.
In methods b and c, both cytological and immunocytochemical analyses of the banding pattern showed, however, that prostate cells can be isolated in fractions above the 1.068 kg/L density (Table 1) .
In method d, PSA and PSMA RT-PCR on the different fractions confirm those data. Moreover, because of its high sensitivity, we found RT-PCR positivity in the granulocyte layer (below 1.077 kg/L density) as well as in the peripheral blood lymphocytes and monocytes layers (1.077 kg/L).
On the one hand, density gradients are cytotoxic and can potentially impair prostate cell viability. On the other hand, the density of prostate cells in vivo may be more heterogeneous than the LNCaP cell line. Thus, according to the manufacturer's recommendations, some or even all circulating cancer cells will not be recovered at the expected interface. Because density gradients are based on physical features of nucleated cells, the respective concentrations of cancer and healthy blood cells will not change their position in the gradient layers. PSMA and PSA RT-nested PCR assays on samples treated by hypoosmotic lysis were consistently positive, whereas a greater variability was observed with gradient separations (data non shown). Therefore, at any tumor cell ratio, gradientbased optimization of the harvest of prostate cells requires recovery of the whole fraction above the first interface and, for some gradients, part of the third fraction. The large volume collected (and the corresponding amount of PNBC cells) will lower the relative concentration of epithelial cells. Furthermore, the extraction of specific prostate messenger RNA by these preparations is no better than that obtained by ammonium chloride procedure (Fig. 1b) .
In contrast to gradient separation methods, hypoosmotic red blood cell lysis with ammonium chloride, which appears smoother than DEPC-treated water, fulfills the requirement for an efficient PNBC extraction mean.
Our goal was to assess a panel of conditions widely used to harvest circulating epithelial cells to delineate guidelines for extraction of cancer cells before RT-PCR. The model of LNCaP cells used in this study may not exactly mimic the behavior of prostate cancer cells in vivo, where density is more heterogeneous. The current results clearly indicate that time-consuming and expensive density gradients for blood cell separation do not give better results than easy and cost-effective red blood cell lysis.
This study was supported in part by grants from the Association de Recherche contre le Cancer (ARC 1367) and from the Association de Recherche sur les Tumeurs de la Prostate (ARTP). The prime role of cholesterol in the pathogenesis of atherosclerosis is almost universally accepted. Vitamins E and K 1 , two fat-soluble vitamins associated with lipoproteins, appear to have antiatheroma properties. Paradoxically, there are good linear correlations of vitamins E and K 1 with plasma cholesterol concentrations. From an epidemiologist point of view, both vitamins K 1 and E could be regarded as being atherogenic. From the point of view of a biochemist, these vitamins may be regarded as antiatherogenic.
Epidemiological studies demonstrate an exponential relationship between increased plasma cholesterol, specifically LDL-cholesterol, and coronary heart disease because of atherosclerosis. Mutations of both the LDL receptor and LDL may be responsible for the loss of recognition between the LDL receptor and the LDL particle, leading to high plasma cholesterol concentrations. Macrophages take up lipoproteins via two receptor-mediated processes, the LDL receptor and a scavenger receptor capable of binding and internalizing various "modified" lipoproteins. The scavenger receptor recognizes apoprotein Bcontaining lipoproteins that have been modified generally with an increased negative charge. This change may be experimentally induced by acetylation or by reaction with malondialdehyde (1). In vivo peroxidative modifications of apoprotein B produce a series of changes of this apoprotein, which render it recognizable and ingestible by the scavenger receptor (2) (3) (4) (5) . This receptor is essentially unregulated, in contrast to the classical LDL receptor, and consequently, pronounced accumulation of cholesteryl ester in macrophages ensues, producing foam cell formation, the hallmark of atheroma (5) .
Vitamin E inhibits lipid peroxidation and prevents formation of malondialdehyde. Independent studies (6, 7) have shown that modification of LDL by cells that produces increased susceptibility to oxidation is inhibited by antioxidants such as vitamin E. Consequently, it may be deduced that vitamin E has antiatheroma properties. Calcification occurs early in the development of atherosclerotic plaques. Calcium phosphate (hydroxyapatite) precipitates by a mechanism similar to active bone formation and is vitamin K-dependent (8) . ␥-Carboxyglutamic acid (Gla)-proteins have been identified in calcified atherosclerotic plaques. The formation of Gla-proteins is dependent on vitamin K. These Gla-containing proteins have a very high affinity for hydroxyapatite. The only known function of these proteins is to bind calcium (9 -11) . It has been suggested that Gla-proteins may be actively related to atherosclerotic calcification (11, 12) . Decarboxylation of Gla residues to glutamyl residues greatly diminishes the affinity of Gla-containing proteins for hydroxyapatite (9 -11) . Paradoxically these Gla-proteins may inhibit precipitation and do not interfere with normal calcium homeostasis (13). Thus, these proteins may have opposing roles of facilitator or inhibitor of calcification of plaques depending on other local factors. Atherosclerotic arteries contain only ϳ30% of the carboxylase activity formed in healthy arterial segments (14). Vitamin K, in addition, has antioxidant properties (15). Thus vitamin K, like vitamin E, appears to have antiatheroma properties, with vitamin K being a promoter of dystropic calcification in certain circumstances.
It has been reported previously that concentrations of vitamin E in serum vary depending on the amount of lipid (16) and apoproteins (Cham et al., submitted for publication). We now present further evidence that there are significant correlations between wide concentration 
